According to UCLA Health, semaglutide was the first drug approved since 2014 specifically for chronic weight management in the majority of American adults who are classified as overweight or obese, yet insurance treatment of that weight-loss indication still lags well behind how insurers treat the diabetes indication for the same molecule
Human and animal consumption is strictly not permitted
Consuming liquid nutrition is great for stimulating the digestive process, increasing nutrient absorption, and improving gut health
Velzquez-Zavala M, Pen-Escalante IE, Zepeda-Bautista R, Jimnez-Arellanes MA
In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
To reflect this, the stylized, medical cross in our new logo embodies the human life cycle
